The prevalence of weight concerns in a smoking abstinence clinical trial

Matthew M. Clark; Richard D. Hurt; Ivana T. Croghan; Christi A. Patten; Paul Novotny; Jeff A. Sloan; Shaker R. Dakhil; Gary A. Croghan; Edward J. Wos; Kendrith M. Rowland; Albert Bernath; Roscoe F. Morton; Sachdex P. Thomas; Loren K. Tschetter; Stewart Garneau; Philip J. Stella; Larry P. Ebbert; Donald B. Wender; Charles L. Loprinzi

doi:10.1016/j.addbeh.2005.08.011

The prevalence of weight concerns in a smoking abstinence clinical trial

Matthew M. Clark, Richard D. Hurt, Ivana T. Croghan, Christi A. Patten, Paul Novotny, Jeff A. Sloan, Shaker R. Dakhil, Gary A. Croghan, Edward J. Wos, Kendrith M. Rowland, Albert Bernath, Roscoe F. Morton, Sachdex P. Thomas, Loren K. Tschetter, Stewart Garneau, Philip J. Stella, Larry P. Ebbert, Donald B. Wender, Charles L. Loprinzi

Research output: Contribution to journal › Article › peer-review

92 Scopus citations

Abstract

Recent research has demonstrated there is a high prevalence of weight concerns in smokers and that smokers with weight concerns may respond poorly to treatment for tobacco dependence. Most studies have focused only on females or have consisted of small samples. In this study of a 12-week randomized trial of nicotine inhaler, bupropion or both for smoking cessation, 50% of the 1012 female smokers and 26% of the 680 male smokers, at study entry, were weight concerned. In examining the impact of weight concerns on the 12-week point-prevalence smoking abstinence, 26% of non-weight-concerned smokers quit smoking compared to 22% of weight-concerned smokers (p = 0.06). This study, which includes a large sample of both genders, provides further evidence that approximately half of females who are seeking smoking cessation treatment are weight concerned and that one quarter of male smokers are weight concerned. Additionally, being weight concerned may impact the short-term success rates of stopping smoking using pharmacotherapy.

Original language	English (US)
Pages (from-to)	1144-1152
Number of pages	9
Journal	Addictive Behaviors
Volume	31
Issue number	7
DOIs	https://doi.org/10.1016/j.addbeh.2005.08.011
State	Published - Jul 2006

Keywords

Smoking cessation
Weight concerns

ASJC Scopus subject areas

Medicine (miscellaneous)
Clinical Psychology
Toxicology
Psychiatry and Mental health

Access to Document

10.1016/j.addbeh.2005.08.011

Cite this

Clark, M. M., Hurt, R. D., Croghan, I. T., Patten, C. A., Novotny, P., Sloan, J. A., Dakhil, S. R., Croghan, G. A., Wos, E. J., Rowland, K. M., Bernath, A., Morton, R. F., Thomas, S. P., Tschetter, L. K., Garneau, S., Stella, P. J., Ebbert, L. P., Wender, D. B., & Loprinzi, C. L. (2006). The prevalence of weight concerns in a smoking abstinence clinical trial. Addictive Behaviors, 31(7), 1144-1152. https://doi.org/10.1016/j.addbeh.2005.08.011

Clark, MM, Hurt, RD, Croghan, IT , Patten, CA, Novotny, P, Sloan, JA, Dakhil, SR, Croghan, GA, Wos, EJ, Rowland, KM, Bernath, A, Morton, RF, Thomas, SP, Tschetter, LK, Garneau, S, Stella, PJ, Ebbert, LP, Wender, DB & Loprinzi, CL 2006, 'The prevalence of weight concerns in a smoking abstinence clinical trial', Addictive Behaviors, vol. 31, no. 7, pp. 1144-1152. https://doi.org/10.1016/j.addbeh.2005.08.011

@article{0def35acffa54646b40a492458875f03,

title = "The prevalence of weight concerns in a smoking abstinence clinical trial",

abstract = "Recent research has demonstrated there is a high prevalence of weight concerns in smokers and that smokers with weight concerns may respond poorly to treatment for tobacco dependence. Most studies have focused only on females or have consisted of small samples. In this study of a 12-week randomized trial of nicotine inhaler, bupropion or both for smoking cessation, 50% of the 1012 female smokers and 26% of the 680 male smokers, at study entry, were weight concerned. In examining the impact of weight concerns on the 12-week point-prevalence smoking abstinence, 26% of non-weight-concerned smokers quit smoking compared to 22% of weight-concerned smokers (p = 0.06). This study, which includes a large sample of both genders, provides further evidence that approximately half of females who are seeking smoking cessation treatment are weight concerned and that one quarter of male smokers are weight concerned. Additionally, being weight concerned may impact the short-term success rates of stopping smoking using pharmacotherapy.",

keywords = "Smoking cessation, Weight concerns",

author = "Clark, {Matthew M.} and Hurt, {Richard D.} and Croghan, {Ivana T.} and Patten, {Christi A.} and Paul Novotny and Sloan, {Jeff A.} and Dakhil, {Shaker R.} and Croghan, {Gary A.} and Wos, {Edward J.} and Rowland, {Kendrith M.} and Albert Bernath and Morton, {Roscoe F.} and Thomas, {Sachdex P.} and Tschetter, {Loren K.} and Stewart Garneau and Stella, {Philip J.} and Ebbert, {Larry P.} and Wender, {Donald B.} and Loprinzi, {Charles L.}",

note = "Funding Information: Support for this trial was provided by the National Cancer Institute through the North Central Cancer Treatment Group. Medication was supplied by Glaxo Wellcome and Pharmacia Pharmaceuticals. This study was conducted as a collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic and was supported in part by Public Health Service grants CA-25224, CA-37404, CA-15083, CA-63826, CA-35195, CA-35448, CA-35431, CA-35101, CA-35113, CA-35103, CA-52352, and CA-63848. ",

year = "2006",

month = jul,

doi = "10.1016/j.addbeh.2005.08.011",

language = "English (US)",

volume = "31",

pages = "1144--1152",

journal = "Addictive Behaviors",

issn = "0306-4603",

publisher = "Elsevier Limited",

number = "7",

}

TY - JOUR

T1 - The prevalence of weight concerns in a smoking abstinence clinical trial

AU - Clark, Matthew M.

AU - Hurt, Richard D.

AU - Croghan, Ivana T.

AU - Patten, Christi A.

AU - Novotny, Paul

AU - Sloan, Jeff A.

AU - Dakhil, Shaker R.

AU - Croghan, Gary A.

AU - Wos, Edward J.

AU - Rowland, Kendrith M.

AU - Bernath, Albert

AU - Morton, Roscoe F.

AU - Thomas, Sachdex P.

AU - Tschetter, Loren K.

AU - Garneau, Stewart

AU - Stella, Philip J.

AU - Ebbert, Larry P.

AU - Wender, Donald B.

AU - Loprinzi, Charles L.

N1 - Funding Information: Support for this trial was provided by the National Cancer Institute through the North Central Cancer Treatment Group. Medication was supplied by Glaxo Wellcome and Pharmacia Pharmaceuticals. This study was conducted as a collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic and was supported in part by Public Health Service grants CA-25224, CA-37404, CA-15083, CA-63826, CA-35195, CA-35448, CA-35431, CA-35101, CA-35113, CA-35103, CA-52352, and CA-63848.

PY - 2006/7

Y1 - 2006/7

N2 - Recent research has demonstrated there is a high prevalence of weight concerns in smokers and that smokers with weight concerns may respond poorly to treatment for tobacco dependence. Most studies have focused only on females or have consisted of small samples. In this study of a 12-week randomized trial of nicotine inhaler, bupropion or both for smoking cessation, 50% of the 1012 female smokers and 26% of the 680 male smokers, at study entry, were weight concerned. In examining the impact of weight concerns on the 12-week point-prevalence smoking abstinence, 26% of non-weight-concerned smokers quit smoking compared to 22% of weight-concerned smokers (p = 0.06). This study, which includes a large sample of both genders, provides further evidence that approximately half of females who are seeking smoking cessation treatment are weight concerned and that one quarter of male smokers are weight concerned. Additionally, being weight concerned may impact the short-term success rates of stopping smoking using pharmacotherapy.

AB - Recent research has demonstrated there is a high prevalence of weight concerns in smokers and that smokers with weight concerns may respond poorly to treatment for tobacco dependence. Most studies have focused only on females or have consisted of small samples. In this study of a 12-week randomized trial of nicotine inhaler, bupropion or both for smoking cessation, 50% of the 1012 female smokers and 26% of the 680 male smokers, at study entry, were weight concerned. In examining the impact of weight concerns on the 12-week point-prevalence smoking abstinence, 26% of non-weight-concerned smokers quit smoking compared to 22% of weight-concerned smokers (p = 0.06). This study, which includes a large sample of both genders, provides further evidence that approximately half of females who are seeking smoking cessation treatment are weight concerned and that one quarter of male smokers are weight concerned. Additionally, being weight concerned may impact the short-term success rates of stopping smoking using pharmacotherapy.

KW - Smoking cessation

KW - Weight concerns

UR - http://www.scopus.com/inward/record.url?scp=33745219641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745219641&partnerID=8YFLogxK

U2 - 10.1016/j.addbeh.2005.08.011

DO - 10.1016/j.addbeh.2005.08.011

M3 - Article

C2 - 16137833

AN - SCOPUS:33745219641

SN - 0306-4603

VL - 31

SP - 1144

EP - 1152

JO - Addictive Behaviors

JF - Addictive Behaviors

IS - 7

ER -

The prevalence of weight concerns in a smoking abstinence clinical trial

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this